HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Estee Lauder Companies

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder Companies: Adds five members to its Board of Directors, increasing the board to seven. Marshall Rose of The Georgetown Group; P. Roy Vagelos, chairman Regeneron Pharmaceuticals; business consultant Faye Wattleton; Estee Lauder Companies President and Chief Operating Officer Fred Langhammer; and William Lauder, president, Origins, join existing members Leonard Lauder, Estee Lauder chairman and CEO; and Ronald Lauder, Clinique Labs and Estee Lauder International chairman. Two additional directors will be added to the board at a subsequent meeting. The board expansion follows the company's Sept. 21 announcement of an initial public offering...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002535

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel